Previous symbols: MODY3, TCF1. Aliases: HNF1, LFB1, HNF1α.
HNF1A (HNF1 homeobox A) is named by 5 disorder entries.
Two entries type HNF1A as causative, Diabetes mellitus; and Hyperinsulinemic Hypoglycemia, both with germline variants (Diabetes mellitus; and Hyperinsulinemic Hypoglycemia). In Hyperinsulinemic Hypoglycemia it shares the node Transcription Factor Dysregulation of the Beta-Cell Secretory Program with HNF4A. In Diabetes mellitus the record is scoped to the monogenic diabetes subtype, for which ClinGen rates the gene definitive, and the gene sits on Monogenic Beta-Cell Dysfunction. Gestational Diabetes Mellitus types it as susceptibility.
Two entries name HNF1A without a genetic record for it: Congenital Isolated Hyperinsulinism; and Type 2 Diabetes Mellitus. In Congenital Isolated Hyperinsulinism the gene appears only on a subtype, and that entry's own evidence on HNF1A hyperinsulinism is mixed.
The KB annotates HNF1A nodes with insulin secretion; and regulation of insulin secretion, while HNF1A itself is a homeodomain transcription activator; the Hyperinsulinemic Hypoglycemia node binds DNA-binding transcription activator activity as decreased. The ai-gene-review layer pinned in the ingest lists 0 core-function terms for HNF1A, so the layers share 0 GO terms; an upstream review centred on DNA-binding transcription activator activity is being completed.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Diabetes mellitus |
causative
germline
CLINGEN: definitive (monogenic diabetes)
|
mechanism: Monogenic Beta-Cell Dysfunction
subtype: maturity-onset diabetes of the young type 3
scoped to subtype: monogenic diabetes
|
| Gestational Diabetes Mellitus | susceptibility germline | |
| Hyperinsulinemic Hypoglycemia | causative germline |
mechanism: Transcription Factor Dysregulation of the Beta-Cell Secretory Program
|
| Congenital Isolated Hyperinsulinism | no genetic record |
subtype: HNF4A/HNF1A-HI
|
| Type 2 Diabetes Mellitus | no genetic record |
computational model: Topp Beta-Cell Mass / Insulin / Glucose Model
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| monogenic diabetes MONDO:0015967 | AD | Definitive 2018-10-05 |
Diabetes mellitus
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.